CSIMarket



Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Net Cash Flow Growth by Quarter and Year

Merck And Co Inc 's Net Cash Flow results by quarter and year




MRK Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -1,879.00 764.00 1,967.00
III Quarter September - 1,416.00 -3,746.00 -
II Quarter June - 1,619.00 3,687.00 -1,307.00
I Quarter March 447.00 -1,142.00 -2,474.00 -
FY   447.00 14.00 -1,769.00 660.00



MRK Net Cash Flow first quarter 2022 Y/Y Growth Comment
Merck and Co Inc in the first quarter 2022 achieved Net Cash Flow of $ 447.00 millions compare to net cash outflow recorded in same quarter a year ago.

Among companies who have reported first quarter 2022 results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year Net Cash Flow results in the first quarter 2022. While Merck And Co Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 7 in the first quarter 2022.




MRK Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - -61.16 % -
III Quarter September - - - -
II Quarter June - -56.09 % - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Merck And Co Inc 's first quarter 2022 Net Cash Flow $ 447.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2021 Net Cash Flow $ -1,142.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Net Cash Flow Growth >>


MRK Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - -12.54 % - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #2
Overall #7

Net Cash Flow Y/Y Growth Statistics
High Average Low
11350 % 605.45 % -99.47 %
(Mar 31 2022)   (Dec 31 2021)
Net Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #2
Overall #7
Net Cash Flow Y/Y Growth Statistics
High Average Low
11350 % 605.45 % -99.47 %
(Mar 31 2022)   (Dec 31 2021)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Merck And Co Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
17008.42 % 806.4 % -100 %
(Dec. 30, 2005)  


MRK's I. Quarter Q/Q Net Cash Flow Comment
This reversal of fortune I. Quarter 2022where Merck and Co Inc posted Net Cash Flow of $ 447.00 millions may be starting point of better business climet.Merck and Co Inc announced in the I. Quarter 2022 Net Cash Flow of $ 447.00 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is 0.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Net Cash Flow Q/Q Growth Statistics
High Average Low
17008.42 % 806.4 % -100 %
(Dec. 30, 2005)  


MRK's I. Quarter Q/Q Net Cash Flow Comment
Improvement I. Quarter 2022where Merck and Co Inc published Net Cash Flow of $ 447.00 millions may is inception of improved business climet.Merck and Co Inc announced in the I. Quarter 2022 Net Cash Flow of $ 447.00 millions compare to net cash outflow recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential Net Cash Flow growth. While Merck And Co Inc 's Net Cash Flow growth quarter on quarter, overall rank is 0.


Merck And Co Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Net Cash Flow 12 Months Ending $ 1,603.00 $ 14.00 $ 2,657.00 $ -2,505.00 $ -437.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) 11350 % -99.47 % - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 7 # 986 # 0 # 0 # 0




Cumulative Net Cash Flow growth Comment
In the Mar 31 2022 period, Merck And Co Inc had cumulative twelve months Net Cash Flow of $ 1,603 millions compare to net cash outflow of $ -437 millions a year ago.
Even more so, not just that MRK has regained the prosperity, the company is, as of now gaining momentum with better then normal Net Cash Flow gain, from the twelve months ending in the quarter before of 11350 % from $14 millions.
It is progress, but very slow one, reporting beneth average 11350 % Net Cash Flow increase, from $14 millions from the twelve months ending in the quarter Dec 31 2021.

Merck and Co Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
11350 %
605.45 %
-99.47 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
1250.79 %
278.19 %
-98.66 %
(Dec. 30, 2009)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 2
S&P 500 # 7
Cumulative Net Cash Flow growth Comment
In the Mar 31 2022 period, Merck And Co Inc had cumulative twelve months Net Cash Flow of $ 1,603 millions compare to net cash outflow of $ -437 millions a year ago.
Even more so, not just that MRK has restored the profitability, Merck And Co Inc is, as of now gaining momentum and showing better then normal Net Cash Flow rise, from the period from Dec 31 2021 to Mar 31 2021 of 11350 % from $14 millions.
Singns of progress, but very slow one, recording below average 11350 % Net Cash Flow advance, from $14 millions from the twelve months ending in the quarter Dec 31 2021 Alexander Anderson mentioned.

Merck and Co Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
11350 %
605.45 %
-99.47 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
1250.79 %
278.19 %
-98.66 %
(Dec. 30, 2009)  


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 2
S&P 500 # 7




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
MRK's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for MRK's Competitors
Net Cash Flow Growth for Merck And Co Inc 's Suppliers
Net Cash Flow Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2022
Quidel Corporation-3.73%$ -3.732 millions
Lineage Cell Therapeutics Inc -5.12%$ -5.116 millions
Tandem Diabetes Care Inc -14.05%$ -14.050 millions
Eventbrite Inc -14.36%$ -14.358 millions
Abcellera Biologics Inc -23.09%$ -23.087 millions
China Health Industries Holdings Inc -23.82%$ -23.817 millions
Cardiovascular Systems Inc -29.81%$ -29.806 millions
Aclaris Therapeutics Inc -31.89%$ -31.892 millions
Prophase Labs Inc -33.82%$ -33.816 millions
Assertio Holdings inc -38.93%$ -38.930 millions
Co diagnostics Inc -40.49%$ -40.492 millions
International Stem Cell Corporation-46.96%$ -46.963 millions
Intra cellular Therapies Inc -47.19%$ -47.193 millions
Phibro Animal Health Corp-49.46%$ -49.461 millions
Landos Biopharma Inc -51.20%$ -51.202 millions
Plus Therapeutics Inc -53.47%$ -53.467 millions
Clearside Biomedical Inc -55.58%$ -55.576 millions
Geovax Labs Inc -55.89%$ -55.891 millions
Diversified Healthcare Trust-55.98%$ -55.979 millions
Ridgefield Acquisition Corp-56.53%$ -56.530 millions
Conmed Corporation-57.32%$ -57.325 millions
Innoviva Inc -58.03%$ -58.034 millions
Apollo Medical Holdings Inc -59.31%$ -59.306 millions
Dariohealth Corp -62.48%$ -62.484 millions
Relmada Therapeutics Inc -62.49%$ -62.485 millions
Aravive Inc -64.72%$ -64.715 millions
Nevro Corp -64.80%$ -64.804 millions
Select Medical Holdings Corp-67.34%$ -67.340 millions
Eiger Biopharmaceuticals Inc -69.40%$ -69.400 millions
Assembly Biosciences inc -70.51%$ -70.509 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ANNO's Profile

Stock Price

ANNO's Financials

Business Description

Fundamentals

Charts & Quotes

ANNO's News

Suppliers

ANNO's Competitors

Customers & Markets

Economic Indicators

ANNO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071